Pharsight

Vyteris patents expiration

1. Lidosite Topical System Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6385488 VYTERIS Circuits for increasing the reliability of an iontophoretic system
Sep, 2013

(10 years ago)

US6862473 VYTERIS Iontophoretic drug delivery device and reservoir and method of making same
Sep, 2013

(10 years ago)

US6377847 VYTERIS Iontophoretic drug delivery device and reservoir and method of making same
Sep, 2013

(10 years ago)

US5873850 VYTERIS Locking and disfiguring mechanism for an iontophoretic system
Sep, 2013

(10 years ago)

US5246418 VYTERIS Iontophresis system having features for reducing skin irritation
Sep, 2013

(10 years ago)

US6629968 VYTERIS Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
Jun, 2020

(3 years ago)

US6635045 VYTERIS Electrodes and method for manufacturing electrodes for electrically assisted drug delivery
Jun, 2021

(2 years ago)

Drugs and Companies using EPINEPHRINE; LIDOCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 06 May, 2004

Treatment: NA

Dosage: PATCH;IONTOPHORESIS, TOPICAL

More Information on Dosage

LIDOSITE TOPICAL SYSTEM KIT family patents

Family Patents